PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Public Health and Pediatric Sciences, University of Turin - Medical School, Turin, Italy.\', \'Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.\', \'Department of Public Health and Pediatric Sciences, University of Turin - Medical School, Turin, Italy; CAAD Center for Translational Research on Autoimmune and Allergic Disease, University of Piemonte Orientale, Novara Medical School, Italy.\', \'Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.\', \'Department of Public Health and Pediatric Sciences, University of Turin - Medical School, Turin, Italy; CAAD Center for Translational Research on Autoimmune and Allergic Disease, University of Piemonte Orientale, Novara Medical School, Italy. Electronic address: marco.deandrea@unito.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(22)00046-810.1016/j.antiviral.2022.105278
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 35288208
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all